Cargando…
The management of metastatic GIST: current standard and investigational therapeutics
Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor of the gastrointestinal tract. The majority of GISTs harbor gain of function mutations in either KIT or PDGFRα. Determination of the GIST molecular subtype upon diagnosis is important because this information informs therapeu...
Autores principales: | Kelly, Ciara M., Gutierrez Sainz, Laura, Chi, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786896/ https://www.ncbi.nlm.nih.gov/pubmed/33402214 http://dx.doi.org/10.1186/s13045-020-01026-6 |
Ejemplares similares
-
Clinical and therapeutic considerations of GIST
por: Gheorghe, M, et al.
Publicado: (2014) -
Current management and prognostic features for gastrointestinal stromal tumor (GIST)
por: Lamba, Gurpreet, et al.
Publicado: (2012) -
Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
por: Catalano, Fabio, et al.
Publicado: (2023) -
Case report of diffusely metastatic rectal GIST
por: Puckett, Yana, et al.
Publicado: (2017) -
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update
por: Schipani, Angela, et al.
Publicado: (2023)